Rocha-Singh K - Search Results

1

Therapeutic angiogenesis with recombinant fibroblast growth factor-2 for intermittent claudication (the TRAFFIC study): a randomised trial.

Lederman RJ, Mendelsohn FO, Anderson RD, Saucedo JF, Tenaglia AN, Hermiller JB, Hillegass WB, Rocha-Singh K, Moon TE, Whitehouse MJ, Annex BH; TRAFFIC Investigators. Lederman RJ, et al. Lancet. 2002 Jun 15;359(9323):2053-8. doi: 10.1016/s0140-6736(02)08937-7. Lancet. 2002. PMID: 12086757 Clinical Trial.

2

Design of the therapeutic angiogenesis with recombinant fibroblast growth factor-2 for intermittent claudication (TRAFFIC) trial.

Lederman RJ, Tenaglia AN, Anderson RD, Hermiller JB, Rocha-Singh K, Mendelsohn FO, Hiatt WR, Moon T, Whitehouse MJ, Annex BH. Lederman RJ, et al. Am J Cardiol. 2001 Jul 15;88(2):192-5, A6-7. doi: 10.1016/s0002-9149(01)01622-8. Am J Cardiol. 2001. PMID: 11448424 Clinical Trial.

3

Results from a phase II multicenter, double-blind placebo-controlled study of Del-1 (VLTS-589) for intermittent claudication in subjects with peripheral arterial disease.

Grossman PM, Mendelsohn F, Henry TD, Hermiller JB, Litt M, Saucedo JF, Weiss RJ, Kandzari DE, Kleiman N, Anderson RD, Gottlieb D, Karlsberg R, Snell J, Rocha-Singh K. Grossman PM, et al. Am Heart J. 2007 May;153(5):874-80. doi: 10.1016/j.ahj.2007.01.038. Am Heart J. 2007. PMID: 17452167 Clinical Trial.

4

A controlled trial of renal denervation for resistant hypertension.

Bhatt DL, Kandzari DE, O'Neill WW, D'Agostino R, Flack JM, Katzen BT, Leon MB, Liu M, Mauri L, Negoita M, Cohen SA, Oparil S, Rocha-Singh K, Townsend RR, Bakris GL; SYMPLICITY HTN-3 Investigators. Bhatt DL, et al. N Engl J Med. 2014 Apr 10;370(15):1393-401. doi: 10.1056/NEJMoa1402670. Epub 2014 Mar 29. N Engl J Med. 2014. PMID: 24678939 Free article. Clinical Trial.

5

Evaluation of renal nerve morphological changes and norepinephrine levels following treatment with novel bipolar radiofrequency delivery systems in a porcine model.

Cohen-Mazor M, Mathur P, Stanley JR, Mendelsohn FO, Lee H, Baird R, Zani BG, Markham PM, Rocha-Singh K. Cohen-Mazor M, et al. J Hypertens. 2014 Aug;32(8):1678-91; discussion 1691-2. doi: 10.1097/HJH.0000000000000236. J Hypertens. 2014. PMID: 24875181 Free PMC article.

6

Intracoronary administration of recombinant human vascular endothelial growth factor to patients with coronary artery disease.

Henry TD, Rocha-Singh K, Isner JM, Kereiakes DJ, Giordano FJ, Simons M, Losordo DW, Hendel RC, Bonow RO, Eppler SM, Zioncheck TF, Holmgren EB, McCluskey ER. Henry TD, et al. Am Heart J. 2001 Nov;142(5):872-80. doi: 10.1067/mhj.2001.118471. Am Heart J. 2001. PMID: 11685177

7

Long-term outcomes after catheter-based renal artery denervation for resistant hypertension: final follow-up of the randomised SYMPLICITY HTN-3 Trial.

Bhatt DL, Vaduganathan M, Kandzari DE, Leon MB, Rocha-Singh K, Townsend RR, Katzen BT, Oparil S, Brar S, DeBruin V, Fahy M, Bakris GL; SYMPLICITY HTN-3 Steering Committee Investigators. Bhatt DL, et al. Among authors: rocha singh k. Lancet. 2022 Oct 22;400(10361):1405-1416. doi: 10.1016/S0140-6736(22)01787-1. Epub 2022 Sep 18. Lancet. 2022. PMID: 36130612 Clinical Trial.

8

Effect of intracoronary recombinant human vascular endothelial growth factor on myocardial perfusion: evidence for a dose-dependent effect.

Hendel RC, Henry TD, Rocha-Singh K, Isner JM, Kereiakes DJ, Giordano FJ, Simons M, Bonow RO. Hendel RC, et al. Circulation. 2000 Jan 18;101(2):118-21. doi: 10.1161/01.cir.101.2.118. Circulation. 2000. PMID: 10637195 Clinical Trial.

9

One-Year Outcomes Following Directional Atherectomy of Popliteal Artery Lesions: Subgroup Analysis of the Prospective, Multicenter DEFINITIVE LE Trial.

Rastan A, McKinsey JF, Garcia LA, Rocha-Singh KJ, Jaff MR, Harlin S, Kamat S, Janzer S, Zeller T. Rastan A, et al. J Endovasc Ther. 2018 Feb;25(1):100-108. doi: 10.1177/1526602817740133. Epub 2017 Nov 9. J Endovasc Ther. 2018. PMID: 29117818 Free PMC article. Clinical Trial.

10

Percutaneous renal denervation in patients with treatment-resistant hypertension: final 3-year report of the Symplicity HTN-1 study.

Krum H, Schlaich MP, Sobotka PA, Böhm M, Mahfoud F, Rocha-Singh K, Katholi R, Esler MD. Krum H, et al. Lancet. 2014 Feb 15;383(9917):622-9. doi: 10.1016/S0140-6736(13)62192-3. Epub 2013 Nov 7. Lancet. 2014. PMID: 24210779 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

96 results

Search Page